Dr. Devanshi Kajal, MD

Dr. Kajal practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Kajal's NPI, 1699384933, was assigned on July 22, 2020. Dr. Kajal holds North Carolina license 2023-02349.

Dr. Kajal's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Dr. Kajal's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. The medical group on file is ECU Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kajal practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Kajal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kajal is licensed in North Carolina.

CMS data shows 624 Medicare services from Dr. Kajal across 6 procedure codes in 2024, for 259 Medicare patients. Medicare paid $45,432 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 259 Medicare patients who saw Dr. Kajal in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kajal's median patient age at 72, with 50% women.

In 2024, Dr. Kajal wrote 355 Medicare Part D claims for 119 patients. 86% of them were for generic drugs. CMS names the drug for 79 of them, across 5 drugs with 11 or more claims each, at $710 in total drug cost. In 2023, CMS named 116 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Kajal for performance year 2024, reported through an alternative payment model (APM). Dr. Kajal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Dr. Kajal from 11 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $117.